Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group studyMarilyn L. Slovak, Frederick R. Appelbaum, Elizabeth Paietta et al.|Blood|2000Cited by 1.6k
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemiaStephen H. Petersdorf, Frederick R. Appelbaum, Kenneth J. Kopecky et al.|Blood|2013Cited by 632
Immunomodulatory and Antimicrobial Efficacy of Intravenous Immunoglobulin in Bone Marrow TransplantationKeith M. Sullivan, Rainer Storb, Kenneth J. Kopecky et al.|New England Journal of Medicine|1990Cited by 394